Abstract:Aim:To investigate the protective effect of pioglitazone on intracerebral hemorrhage in rats and its possible mechanism.Methods: A total of 72 male SD rats were divided randomly into six groups.Intervention group 1(n=12): Pioglitazone peroxisome proliferator-activated receptor gamma(PPARγ activator) were gastrically administrated 6 h before modeling,and the original dosages were maintained after modeling.Intervention group2(n=12): Pioglitazone were gastrically administrated 6 h before modeling,and were withdrawn after modeling.Intervention group 3(n=12): The drugs were not given before modeling,and were gastrically administrated aftermodeling.Model group 4(n=12): The drugs were not given before and after modeling.Sham operation group(n=12): The rats were performed with needling insertion without injection.Normal group(n=12) was set up.Thedose of gastrically administrated pioglitazone was 15 mg.kg-1.d-1.Rats in each group were sacrificed at 72 h afteroperation.Biochemical detection of the superoxide dismutase(SOD) and malondialdehyde(MDA) concentration of brain tissue were performed.The Western blot was used to determine the PPARγ and caspase-3 proteinexpression in brain tissue.HE and TUNEL staining were used to observe the brain edema and apoptosis respectively.Results: PPARγ activator pioglitazone could significantly reduce the extent of brain edema and inflammatory cellinfiltration of the brain tissue in rats at 72 h after cerebral hemorrhage,as well as reduce the number of apoptoticcells in brain tissue,and enhance the SOD activity and increase the expression of PPARγ,and caspase-3 proteinin brain tissue,and inhibit the MDA levels.The effect of prophylactic administration of pioglitazone beforecerebral hemorrhage was better than that of the treatment after hemorrhage.Conclusion: PPARγ activatorpioglitazone can relieve the hemorrhagic brain injury in the rat brain,and protect the brain,possibly by increasingthe PPARγ protein expression in brain tissue and by enhancing the SOD activity,inhibiting the free radicals levelsin brain tissue and the apoptosis of brain cells.

The effects of PPARγ agonists on long‑termpotentiation and apoptosis in the hippocampusarea of juvenile hypothyroid rats

The effects of pioglitazone and rosiglitazone on liver function in hypothyroid rats

Effects of Rosiglitazone on Serum Levels of Lipids and Inflammatory Factors in Atherosclerotic Rats

Rosiglitazone Via Upregulation of Akt/Enos Pathways Attenuates Dysfunction of Endothelial Progenitor Cells, Induced by Advanced Glycation End Products

Rosiglitazone ameliorates the dysfunction of endothelial progenitor cells induced by advanced glycation end products

Effects of Perinatal Hypothyroidism on Rat Behavior and Its Relation with Apoptosis of Hippocampus Neurons

Rosiglitazone Attenuates Cell Apoptosis Through Antioxidative and Anti-Apoptotic Pathways in the Hippocampi of Spontaneously Hypertensive Rats.

Effects of rosiglitazone on expressions of peroxisome proliferator-activated receptor gamma and TGF-β1 in rats with adriamycin nephrosis

Effects of Analog P165 of Amyloid Precursor Protein 5-Mer Peptide on Learning, Memory and Brain Insulin Receptors in the Rat Model of Cognitive Decline.

Peroxisome Proliferator-Activated Receptor Γ Agonist Rosiglitazone Protects Blood–Brain Barrier Integrity Following Diffuse Axonal Injury by Decreasing the Levels of Inflammatory Mediators Through a Caveolin-1-Dependent Pathway

The effects of PPAR-γ agonist pioglitazone on anxiety and depression-like behaviors in lipopolysaccharide injected rats

Effects of peroxisome proliferator activated receptor γ Pioglitazone on cerebral ischemic injury in rats

Effects of Pioglitazone on Cell Apoptosis and Free Radical Levels in Brain Tissue of Rats withIntracerebral Hemorrhage

Pioglitazone Ameliorates Lipopolysaccharide-Induced Behavioral Impairment, Brain Inflammation, White Matter Injury and Mitochondrial Dysfunction in Neonatal Rats

Effects of Low Doses of Pioglitazone on Resting-State Functional Connectivity in Conscious Rat Brain

The synergistic ameliorative activity of peroxisome proliferator-activated receptor-alpha and gamma agonists, fenofibrate and pioglitazone, on hippocampal neurodegeneration in a rat model of insulin resistance

Effects of long-term treatment with pioglitazone on cognition and glucose metabolism of PS1-KI, 3xTg-AD, and wild-type mice

Effects of Pioglitazone on Treg Cells and Atherosclerosis in Uremic Apoe-/- Mice

Rosiglitazone Exerts an Anti-depressive Effect in Unpredictable Chronic Mild-Stress-Induced Depressive Mice by Maintaining Essential Neuron Autophagy and Inhibiting Excessive Astrocytic Apoptosis

Cell proliferation and neuroblast differentiation in the dentate gyrus of high-fat diet-fed mice are increased after rosiglitazone treatment

Rosiglitazone prevents amyloid-β oligomer-induced impairment of synapse formation and plasticity via increasing dendrite and spine mitochondrial number